Literature DB >> 25811333

Travelling wave solutions of the reaction-diffusion mathematical model of glioblastoma growth: an Abel equation based approach.

Tiberiu Harko1, Man Kwong Mak.   

Abstract

We consider quasi-stationary (travelling wave type) solutions to a nonlinear reaction-diffusion equation with arbitrary, autonomous coefficients, describing the evolution of glioblastomas, aggressive primary brain tumors that are characterized by extensive infiltration into the brain and are highly resistant to treatment. The second order nonlinear equation describing the glioblastoma growth through travelling waves can be reduced to a first order Abel type equation. By using the integrability conditions for the Abel equation several classes of exact travelling wave solutions of the general reaction-diffusion equation that describes glioblastoma growth are obtained, corresponding to different forms of the product of the diffusion and reaction functions. The solutions are obtained by using the Chiellini lemma and the Lemke transformation, respectively, and the corresponding equations represent generalizations of the classical Fisher-Kolmogorov equation. The biological implications of two classes of solutions are also investigated by using both numerical and semi-analytical methods for realistic values of the biological parameters.

Entities:  

Mesh:

Year:  2015        PMID: 25811333     DOI: 10.3934/mbe.2015.12.41

Source DB:  PubMed          Journal:  Math Biosci Eng        ISSN: 1547-1063            Impact factor:   2.080


  2 in total

1.  A Numerical Handling of the Boundary Conditions Imposed by the Skull on an Inhomogeneous Diffusion-Reaction Model of Glioblastoma Invasion Into the Brain: Clinical Validation Aspects.

Authors:  Georgios S Stamatakos; Stavroula G Giatili
Journal:  Cancer Inform       Date:  2017-02-03

2.  Revisiting Fisher-KPP model to interpret the spatial spreading of invasive cell population in biology.

Authors:  Gour Chandra Paul; Dipankar Kumar
Journal:  Heliyon       Date:  2022-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.